Figures & data
Figure 1. —The efficacy of omalizumab in severe asthma. Comparison between atopic and non-atopic patients.
Figure 1. —Continued
Figure 1. —Continued
Journal of Asthma
Volume 50, 2013 - Issue 5
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.